These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24013743)

  • 81. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
    Wang YQ; Qu DH; Wang K
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
    [TBL] [Abstract][Full Text] [Related]  

  • 83. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
    Qin W; Ho L; Wang J; Peskind E; Pasinetti GM
    PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
    Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
    Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
    [TBL] [Abstract][Full Text] [Related]  

  • 86. PDK1: a new therapeutic target for glioblastoma?
    Velpula KK; Tsung AJ
    CNS Oncol; 2014 May; 3(3):177-9. PubMed ID: 25055123
    [No Abstract]   [Full Text] [Related]  

  • 87. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
    Delrieu J; Desmidt T; Camus V; Sourdet S; Boutoleau-Bretonnière C; Mullin E; Vellas B; Payoux P; Lebouvier T;
    Int J Geriatr Psychiatry; 2015 May; 30(5):470-7. PubMed ID: 24953008
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [From prion diseases to Alzheimer's disease: a common therapeutic target, PDK1].
    Pietri M; Alleaume-Butaux A; Launay JM; Kellermann O; Schneider B
    Med Sci (Paris); 2014 Feb; 30(2):139-41. PubMed ID: 24572109
    [No Abstract]   [Full Text] [Related]  

  • 89. SDC2 Stabilization by USP14 Promotes Gastric Cancer Progression through Co-option of PDK1.
    You L; Dou Y; Zhang Y; Xiao H; Lv H; Wei GH; Xu D
    Int J Biol Sci; 2023; 19(11):3483-3498. PubMed ID: 37496999
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9.
    Kaczmarczyk L; Mende Y; Zevnik B; Jackson WS
    PLoS One; 2016; 11(4):e0154604. PubMed ID: 27128441
    [TBL] [Abstract][Full Text] [Related]  

  • 91. α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins.
    Vincent B; Checler F
    Curr Alzheimer Res; 2012 Feb; 9(2):140-56. PubMed ID: 21605031
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Alzheimer's and prion diseases: PDK1 at the crossroads.
    Checler F
    Nat Med; 2013 Sep; 19(9):1088-90. PubMed ID: 24013743
    [TBL] [Abstract][Full Text] [Related]  

  • 94. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
    Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
    Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Neurodegenerative disease: PDK1--a common therapeutic target for AD and prion disease?
    Wood H
    Nat Rev Neurol; 2013 Oct; 9(10):543. PubMed ID: 24018477
    [No Abstract]   [Full Text] [Related]  

  • 96. Neurodegenerative diseases: New kinase targets for Alzheimer's disease.
    Flight MH
    Nat Rev Drug Discov; 2013 Oct; 12(10):739. PubMed ID: 24080693
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.